TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 SEK)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
3,005,004
|
1,963,233
|
1,391,393 |
| Earnings before taxes |
1,009,526
|
481,844
|
276,731 |
| Total assets |
4,319,251
|
3,167,385
|
1,651,606 |
| Current assets |
2,905,176
|
2,173,738
|
872,889 |
| Current liabilities |
2,589,124
|
1,798,342
|
990,174 |
| Equity capital |
871,349
|
458,304
|
300,504 |
| - share capital |
58,934
|
57,819
|
59,857 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
20.2%
|
14.5%
|
18.2% |
| Turnover per employee |
8,586
|
5,609
|
3,975 |
| Profit as a percentage of turnover |
33.6%
|
24.5%
|
19.9% |
| Return on assets (ROA) | |||
| Current ratio |
112.2%
|
120.9%
|
88.2% |
| Return on equity (ROE) |
115.9%
|
105.1%
|
92.1% |
| Change turnover |
1,003,893
|
619,211
|
423,958 |
| Change turnover % |
50%
|
46%
|
44% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.